Physician profile
Noah C Johnson
NPI 1932215092
$18,237.40
in general payments reported to CMS, 2019-2025
67 companies · $2,159 in 2025
The $2,159 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,801 · 2020: $2,144 · 2021: $3,308 · 2022: $2,958 · 2023: $2,573 · 2024: $2,294 · 2025: $2,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,025.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,505.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,964.92 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $1,484.85 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $1,307.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,066.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,028.16 | 2019-2025 | Jardiance, Tradjenta, Spiriva Respimat |
| Novartis Pharmaceuticals Corporation | $980.39 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $648.19 | 2019-2025 | Rexulti |
| Pfizer INC. | $639.09 | 2019-2025 | |
| Allergan, INC. | $544.21 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $511.82 | 2020-2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $369.89 | 2019-2023 | |
| Vanda Pharmaceuticals INC. | $363.11 | 2019-2025 | Fanapt, Hetlioz |
| Janssen Pharmaceuticals, INC | $359.09 | 2019-2022 | |
| Axsome Therapeutics, INC. | $348.18 | 2024-2025 | Auvelity |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.